The Story of CD4+CD28− T Cells Revisited: Solved or Still Ongoing?
CD4+CD28− T cells are a unique type of proinflammatory T cells characterised by blockade of costimulatory CD28 receptor expression at the transcriptional level, which is still reversible by IL-12. In healthy individuals older than 65 years, these cells may accumulate to up to 50% of total CD4+ T lym...
Saved in:
Main Authors: | Kathrin Maly, Michael Schirmer |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2015/348746 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum to “The Story of CD4+CD28− T Cells Revisited: Solved or Still Ongoing?”
by: Kathrin Maly, et al.
Published: (2015-01-01) -
CD3+CD8+CD28− T Lymphocytes in Patients with Lupus Nephritis
by: Marcelina Żabińska, et al.
Published: (2016-01-01) -
The Modulation of PPARγ1 and PPARγ2 mRNA Expression by Ciglitazone in CD3/CD28-Activated Naïve and Memory CD4+ T Cells
by: Mohd Nor Norazmi, et al.
Published: (2012-01-01) -
Circulating CD4+CD28null T Cells May Increase the Risk of an Atherosclerotic Vascular Event Shortly after Kidney Transplantation
by: Michiel G. H. Betjes, et al.
Published: (2013-01-01) -
Classifying Lupus Nephritis: An Ongoing Story
by: Saba Kiremitci, et al.
Published: (2014-01-01)